1. Cytomegalovirus in Renal Transplantation
2. Cytomegalovirus Disease in High-Risk Transplant Recipients Despite Ganciclovir or Valganciclovir Prophylaxis
3. 3. CV Paya . A randomized, double-blind, double dummy, active comparator controlled multi-center study of the efficacy and safety of valganciclovir vs oral ganciclovir for prevention of CMV disease in 372 high-risk (D+/R-) heart, liver, and kidney recipients . A randomized, double-blind, double dummy, active comparator controlled multi-center study of the efficacy and safety of valganciclovir vs oral ganciclovir for prevention of CMV disease in 372 high-risk (D+/R-) heart, liver, and kidney recipients : San Diego, CA (Abstract).
4. Pharmacokinetics of valganciclovir and ganciclovir in renal impairment*